Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Harmony Biosciences logo — A fresh approach to helping patients thrive.

Harmony Biosciences

A fresh approach to helping patients thrive.

Founded 2017 United States United States 273 employees Post Ipo Debt Total: $1.44B Biopharma, Biotechnology +1

General Information

Company Name Harmony Biosciences
Founded Year 2017
Location United States United States +1
Founders / Decision Makers
Team member
Employees 273
Industries Biopharma, Biotechnology, Health Care
Funding Stage Post Ipo Debt
Social

Get notified when Harmony Biosciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Harmony Biosciences

Harmony Biosciences is a biopharma and biotechnology startup, founded in 2017 and headquartered in the United States. The company's slogan, "Patients are at the heart of everything we do," reflects its primary focus on developing and delivering treatments for rare neurological diseases. The organization's ethos revolves around the belief that the convergence of empathy and innovation can significantly enhance the lives of individuals afflicted with neurological disorders. Harmony Biosciences boasts a diverse team of experts representing various disciplines and experiences, all driven by the firm conviction that groundbreaking science can translate into tangible therapeutic possibilities. The company's core mission is to seamlessly transition novel therapies from the clinic to the medicine cabinet, while concurrently offering support to patients, providers, and the communities in which they operate. The company recently secured a significant $185.00M Post-IPO Debt investment on 27 July 2023, highlighting external confidence in its endeavors. As a private investor, recognizing Harmony Biosciences' commitment to addressing unmet medical needs in the realm of neurological diseases could unearth a promising investment opportunity. Moreover, tracking the company's progress and adherence to its stated community guidelines could provide valuable insights into its prospective growth trajectory. In conclusion, Harmony Biosciences' steadfast dedication to fostering innovation in neurological disease treatment, coupled with its recent substantial investment, positions it as a compelling prospect for potential venture capital consideration. For more information, please visit their website at Harmony Biosciences. For additional updates, follow them on Twitter at @Harmonybio.

Taxonomy: Neurological diseases, Rare diseases, Therapeutic treatments, Innovation, Empathy, Clinical research, Medical science, Patient support, Community engagement, Healthcare innovation

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt •••••• - 27 Jul 2023
Post-IPO Equity •••••• - 01 Nov 2021
Post-IPO Equity •••••• 1 •••• •••• 10 Aug 2021
Post-IPO Debt •••••• 1
Investor
10 Aug 2021
Debt Financing •••••• 1
Investor
27 Jan 2020

View All 8 Funding Rounds

Harmony Biosciences Alternatives & Competitors

Harmony Biosciences vs
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. United States

Pioneering innovative therapies for rare diseases, dedicated to enhancing patient quality of life.

55 employees
Biotechnology, Pharmaceutical
Compare Harmony Biosciences vs Leadiant Biosciences, Inc.
Harmony Biosciences vs
Ahammune Biosciences Pvt. Ltd.
Ahammune Biosciences Pvt. Ltd. India

Innovation-led drug discovery company focused on developing drugs targeting skin immune system.

Seed
9 employees
Biotechnology, Health Care
Compare Harmony Biosciences vs Ahammune Biosciences Pvt. Ltd.
Harmony Biosciences vs
Jade Biosciences
Jade Biosciences

On a mission to transform the future of autoimmune care

80 employees
Also compare with: Harmony Biosciences vs Imago BioSciences, Inc. Imago BioSciences, Inc.

FAQ About Harmony Biosciences

A fresh approach to helping patients thrive.
Harmony Biosciences was founded in 2017.
Harmony Biosciences is headquartered in United States.
Harmony Biosciences operates in the following industries: Biopharma, Biotechnology, Health Care.
Harmony Biosciences has approximately 273 employees.
Harmony Biosciences has completed 8 funding rounds, raising a total of $1.44B. The latest funding stage is Post Ipo Debt.
Top alternatives and competitors to Harmony Biosciences include Leadiant Biosciences, Inc., Ahammune Biosciences Pvt. Ltd., Jade Biosciences, Belenos Biosciences Inc., Imago BioSciences, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Harmony Biosciences and Leadiant Biosciences, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Harmony Biosciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy